Pierre Fabre Laboratories Entered into a Drug Discovery Collaboration with Vernalis to Identify Pre-Clinical Candidates Against Multiple Oncology Targets
Shots:
- Under the terms of the agreement, Vernalis is eligible to receive research and clinical milestones along with royalties on marketed products
- The collaboration will combine Vernalis’ expertise & Pierre Fabre Laboratories’ oncology experience for drug discovery and identifying clinical candidates for a wide variety of therapeutic targets in cancer patients
- Vernalis also fragment and structure-based methods to identify small molecules that modulate their activity. Pierre Fabre Laboratories’ commercial portfolio in oncology incl. colorectal, breast & lung cancers, melanoma, hematology, and pre-cancerous skin conditions like actinic keratosis
Ref: PR Newswire | Image: Pierre Fabre Laboratories
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
